semaglutide shortage 2025 🚨 FDA Ends The FDA has officially declared an end to the shortage of semaglutide, the active ingredient in the popular medications Ozempic and Wegovy. This announcement signals a significant Novo Nordisk calls out dangers

Among the most exciting topics were: AI-driven models for glucose monitoring and diabetes management New technologies supporting sustainable weight loss and obesity treatment Personalized approaches to cardiometabolic disease prevention The role of digital health and wearable technologies in everyday clinical practice Longevity and healthy aging through better metabolic control A particularly important area of discussion for my own clinical practice was women's health during the menopausal transition

If no significant changes are identified, then a patient may need to be referred to their provider for a insulin dose adjustment

Active cancer treatment may complicate causation arguments since chemotherapy can cause similar symptoms

Sleep and chronotype

Athletes in contact sports such as boxing, mixed martial arts, football, and rugby face higher risk due to repeated facial impacts